Catalog · Regenerative

BPC-157

Name: BPC-157 Research Peptide
Brand: Ethos Bio
Price: 49.99 USD
Availability: InStock

CAS 137525-51-0 MW 1,419.5 g/mol ≥99.0% Purity

A 15-amino acid synthetic peptide derived from a partial sequence of human gastric protein. Primary research focus: VEGFR2 / ERK1/2 signaling, fibroblast migration, and angiogenesis pathway studies in regenerative biology research.

Quantity per vial

Vials

$49.99

Free cold-chain shipping over $200
Signed COA included with every vial
Batch-pinned ordering for protocol continuity

Research Use Only. This product is sold for research and identification purposes only. Not intended for human dosing, injection, or ingestion.

Mass-Spec Verified

HPLC + LC-MS per batch at Janoshik AG.

99% Purity Threshold

Below-spec lots are destroyed, not sold.

Cold-Chain 2-8°C

Continuous transit temperature logging.

U.S. cGMP Compounded

Domestic manufacturing, full lot traceability.

Mechanism of action

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a fragment of human gastric juice protein. In research models, it has demonstrated activity across several intracellular signaling pathways:

VEGFR2 / nitric oxide pathway — Upregulates VEGF-receptor 2 expression and enhances NO-mediated vasodilation in cultured endothelial cells, supporting research into angiogenesis and tissue-perfusion models.

ERK1/2 / Akt signaling — Activates the MAPK cascade in fibroblasts, with downstream effects on cell proliferation, migration, and extracellular-matrix synthesis observed in in-vitro wound-closure assays.

Growth-hormone receptor modulation — Increases GHR mRNA in tendon fibroblasts and supports growth-factor-receptor density studies in regenerative biology research.

BPC-157 is investigated alongside related research compounds including TB-500 and GHK-Cu for angiogenesis, tendon-fibroblast biology, and tissue-repair pathway research.

Specifications

Compound name	BPC-157 (Body Protection Compound 157)
CAS number	137525-51-0
Sequence	Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular formula	C₆₂H₉₈N₁₆O₂₂
Molecular weight	1,419.5 g/mol
Purity (HPLC)	≥ 99.0%
Identity verification	LC-MS at Janoshik AG
Water content (KF)	≤ 5%
Appearance	White lyophilized powder
Storage	Lyophilized: 2–8°C, sealed. Reconstituted: −20°C.
Shelf life	24 months from synthesis date
Vial sizes	5 mg · 10 mg · 15 mg
Synthesis method	Solid-phase peptide synthesis (SPPS)

Per-lot certificate of analysis

Every shipment of BPC-157 from Ethos Bio includes a signed Certificate of Analysis specific to the lot you receive. Each COA documents:

HPLC purity percentage
LC-MS identity confirmation (within 0.1 Da of theoretical mass)
Karl Fischer water content
Endotoxin profile
Synthesis and testing dates
Cold-chain shipping temperature log
QC Lead signature

COAs are mirrored to your Researcher Portal account within 60 seconds of lot release.

View Certificate of Analysis →

Key research references

Curated bibliography updated quarterly by Ethos Bio scientific advisory:

Sikiric et al. (2018). Stable gastric pentadecapeptide BPC-157: novel therapy in gastrointestinal tract. Curr Pharm Des, 24(18).
Chang et al. (2014). The promoting effect of pentadecapeptide BPC-157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol, 117(11).
Hsieh et al. (2017). Therapeutic potential of pro-angiogenic BPC-157 is associated with VEGFR2 activation. Mol Med Rep, 16(5).
Seiwerth et al. (2014). BPC 157 and standard angiogenic growth factors: gastrointestinal tract healing. Curr Pharm Des, 20(7).
Tkalcevic et al. (2007). Enhancement of wound healing with BPC-157. Eur J Pharmacol, 561(1-3).

Research Use Only — required disclosure

BPC-157, like all Ethos Bio products, is sold strictly for in-vitro and laboratory research use only. This product is:

Not a drug, food, cosmetic, or supplement
Not intended for human or veterinary consumption
Not intended for the diagnosis, treatment, cure, mitigation, or prevention of any disease
Not produced under FDA-enforced sterility, endotoxin, or pyrogen thresholds applicable to therapeutic agents

Sale is restricted to qualified researchers and research institutions, aged 21+. By placing an order you certify that the compound will be used solely for laboratory research purposes consistent with 21 CFR § 201.128.